Abstract
Neurons are highly polarized cells, often with very long processes, which can comprise up to 95% of the cytoplasm. This raises the issue of transporting and turnover of proteins transport. In addition to fast axonal transport, axonal translation has been proposed to be responsible for producing at least some axonal proteins. In multiple experimental models, local synthesis of several proteins has been demonstrated in axons, growth cones, and nerve terminals. Multiple lines of evidence are consistent with the existence of axonal rRNAs, mRNAs, tRNAs, and micro RNAs and micro RNA regulatory proteins (RISC complex). Multiple signalling pathways, including mTOR, may regulate axonal translation. The origin of axonal RNAs is often attributed to transport from the neuronal soma, but evidence supporting cell-to-cell transport from Schwann cells to axons as a source of at least some axonal RNAs is emerging. This intercellular transport will be discussed in the context of normal and regenerative conditions.
Keywords: Axon, local translation, miRNAs, mRNAs, mTOR, transcriptome, UTR, β-actin mRNA, Alpha- and beta-tubulin, energy-filtered transmission EM, periaxoplasmic ribosomal plaques, retinal ganglion cells, immuno-EM
Current Chemical Biology
Title: The Axonal Transcriptome: RNA Localization and Function
Volume: 5 Issue: 2
Author(s): Lucia Canclini, Alejandra Kun, Aldo Calliari, John A. Mercer, Jose R. Sotelo and Jose R. Sotelo-Silveira
Affiliation:
Keywords: Axon, local translation, miRNAs, mRNAs, mTOR, transcriptome, UTR, β-actin mRNA, Alpha- and beta-tubulin, energy-filtered transmission EM, periaxoplasmic ribosomal plaques, retinal ganglion cells, immuno-EM
Abstract: Neurons are highly polarized cells, often with very long processes, which can comprise up to 95% of the cytoplasm. This raises the issue of transporting and turnover of proteins transport. In addition to fast axonal transport, axonal translation has been proposed to be responsible for producing at least some axonal proteins. In multiple experimental models, local synthesis of several proteins has been demonstrated in axons, growth cones, and nerve terminals. Multiple lines of evidence are consistent with the existence of axonal rRNAs, mRNAs, tRNAs, and micro RNAs and micro RNA regulatory proteins (RISC complex). Multiple signalling pathways, including mTOR, may regulate axonal translation. The origin of axonal RNAs is often attributed to transport from the neuronal soma, but evidence supporting cell-to-cell transport from Schwann cells to axons as a source of at least some axonal RNAs is emerging. This intercellular transport will be discussed in the context of normal and regenerative conditions.
Export Options
About this article
Cite this article as:
Canclini Lucia, Kun Alejandra, Calliari Aldo, A. Mercer John, R. Sotelo Jose and R. Sotelo-Silveira Jose, The Axonal Transcriptome: RNA Localization and Function, Current Chemical Biology 2011; 5 (2) . https://dx.doi.org/10.2174/2212796811105020099
DOI https://dx.doi.org/10.2174/2212796811105020099 |
Print ISSN 2212-7968 |
Publisher Name Bentham Science Publisher |
Online ISSN 1872-3136 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
In Vivo MRI in Different Models of Experimental Epilepsy
Current Drug Targets In Vitro and In Vivo Models of Multiple Sclerosis
CNS & Neurological Disorders - Drug Targets T Cell Homeostasis in Centenarians: From the Thymus to the Periphery
Current Pharmaceutical Design Editorial (Thematic Issue: Genetics of Parkinson's Disease and Other Diseases of the Extrapyramidal System)
Current Genomics Conformational Changes and Aggregation of Expanded Polyglutamine Proteins as Therapeutic Targets of the Polyglutamine Diseases: Exposed β-Sheet Hypothesis
Current Pharmaceutical Design Pathogenic Mechanisms and Therapeutic Strategies in Spinobulbar Muscular Atrophy
CNS & Neurological Disorders - Drug Targets MICA Gene and Relevance to Immune Responses in Organ Transplants and Inflammatory, Tumoral and Autoimmune Diseases
Current Immunology Reviews (Discontinued) Pneumonia in the Elderly
Current Respiratory Medicine Reviews Molecular Mechanisms, Emerging Etiological Insights and Models to Test Potential Therapeutic Interventions in Alzheimers Disease
Current Alzheimer Research Combined Therapies for Lysosomal Storage Diseases
Current Molecular Medicine Transglutaminase-Catalyzed Reactions Responsible for the Pathogenesis ofCeliac Disease and Neurodegenerative Diseases: From Basic Biochemistry to Clinic
Current Medicinal Chemistry Management of Peyronie's Disease after Collagenase (Xiaflex:<sup>®</sup>)
Current Drug Targets Autonomic Neural Functions in Space
Current Pharmaceutical Biotechnology Molecular Cytogenetics and Cytogenomics of Brain Diseases
Current Genomics Approaches to Target Profiling of Natural Products
Current Medicinal Chemistry In vitro Generated Mesenchymal Stem Cells: Suitable Tools to Target Insulin Dependent Diabetes Mellitus?
Current Stem Cell Research & Therapy Current Anti-Inflammatory Therapies and the Potential of Secretory Phospholipase A2 Inhibitors in the Design of New Anti-Inflammatory Drugs: A Review of 2012 - 2018
Current Medicinal Chemistry PERK-opathies: An Endoplasmic Reticulum Stress Mechanism Underlying Neurodegeneration
Current Alzheimer Research Targeting Glutamatergic Signaling for the Development of Novel Therapeutics for Mood Disorders
Current Pharmaceutical Design Characterization of Fiber-Forming Peptides and Proteins by Means of Atomic Force Microscopy
Current Protein & Peptide Science